← Back to Search

Continuous Glucose Monitor

CGM4Home for Low Blood Sugar (CGM4Home Trial)

N/A
Waitlist Available
Led By Paulina Cruz Bravo, MD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1 month and 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing the use of a continuous glucose monitor (CGM) called FreeStyle Libre 2 for patients with poorly controlled diabetes. The device is attached to the arm and continuously measures blood sugar levels. The goal is to see if using this device helps improve blood sugar control and quality of life.

Eligible Conditions
  • Low Blood Sugar
  • Diabetes
  • Hypoglycemia
  • Low blood sugar awareness
  • High Blood Sugar
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1 month and 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1 month and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To Determine the Feasibility of Initiating a Continuous Glucose Monitoring in Patients With Diabetes at Hospital Discharge
Secondary study objectives
Mean Change in Self-efficacy at 3 Months
Mean Time in Range Outcomes
Percentage of Patients That Discontinue the CGM

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CGM InterventionExperimental Treatment1 Intervention
All eligible patients will receive a Continuous Glucose Monitor (CGM) prior to hospital discharge after signing an informed consent.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,991 Previous Clinical Trials
2,295,864 Total Patients Enrolled
Paulina Cruz Bravo, MDPrincipal Investigator - Washington University School of Medicine
Washington University School of Medicine
~4 spots leftby Nov 2025